{
  "docId": "019de074-4550-75c8-b409-3e681fefedb4",
  "docSlug": "3148a2a91ddd74e886a30db191b6b33b",
  "documentTitle": "AbCellera | Results Presentation Deck | 23 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 23,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "thesis_headline",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a minimalist design with a central geometric icon and two distinct text blocks defining the company's strategic pillars.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-4550-75c8-b409-3e681fefedb4/4",
  "deckHref": "/decks/019de074-4550-75c8-b409-3e681fefedb4",
  "deckJsonHref": "/decks/019de074-4550-75c8-b409-3e681fefedb4.json",
  "deckAnchorHref": "/decks/019de074-4550-75c8-b409-3e681fefedb4#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.37,
        "x": 0.525,
        "y": 0.71
      },
      "kind": "callout",
      "text": "PHILOSOPHY: Long-term value creation begins with building a great company that can create multiple products.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "24bf9815-0854-47c1-9778-bb17ae2baa01",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.37,
        "x": 0.525,
        "y": 0.44
      },
      "kind": "callout",
      "text": "HYPOTHESIS: Investments in technology can improve the productivity of drug development.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db78269a-7c40-474c-a4a8-593ba7c6278e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.52,
        "w": 0.35,
        "x": 0.106,
        "y": 0.38
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f33f88b3-8989-48a9-a041-a1c5a2a77f96",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.788,
        "x": 0.106,
        "y": 0.09
      },
      "kind": "title",
      "text": "AbCellera is an antibody discovery engine that delivers optimal clinical candidates to the clinic – and to patients – with greater precision and speed.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1139f59e-73f9-4c2d-accd-d90eb006bd8e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Thesis archetype",
      "slug": "thesis-archetype",
      "agent": null,
      "layer": "slide",
      "matchId": "114cc503-2eb4-495f-9dd7-bbb7c058058b",
      "evidence": "This slide presents a clear thesis statement about AbCellera's role as an antibody discovery engine.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 4,
      "from": 3,
      "beatId": "a5cbe623-c725-4d7e-9d82-f304c425137a",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The document presents an overview of AbCellera's business and the need for antibody therapeutics.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5702edfd-b461-4ace-a3f1-79aaa73043cd",
      "evidence": "The document presents the need for antibody therapeutics and the potential consequences of not investing in this area.",
      "position": 0,
      "objective": "The cost of not investing in antibody therapeutics",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}